AUROPHARMA.NSAUROPHARMA.NSNSE
Loading
Operating Income ScalingExpanding
Percentile Rank100
3Y CAGR+15.4%
5Y CAGR+6.5%
Year-over-Year Change
Profit from core business operations before interest and taxes
3Y CAGR
+15.4%/yr
vs +4.2%/yr prior
5Y CAGR
+6.5%/yr
Recent acceleration
Acceleration
+11.2pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.4x
Solid growth
Streak
3 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $120.01B | +14.8% |
| 2024 | $104.50B | +28.9% |
| 2023 | $81.05B | +3.8% |
| 2022 | $78.06B | -17.0% |
| 2021 | $94.03B | +7.2% |
| 2020 | $87.75B | +25.6% |
| 2019 | $69.88B | +5.5% |
| 2018 | $66.24B | +8.8% |
| 2017 | $60.86B | +8.1% |
| 2016 | $56.32B | - |